Safety & Immunogenicity of Immunisations With EN41-UGR7C HIV Vaccine

This study is not yet open for participant recruitment.
Verified April 2013 by PX'Therapeutics
Sponsor:
Collaborator:
European Commission
Information provided by (Responsible Party):
PX'Therapeutics
ClinicalTrials.gov Identifier:
NCT01827397
First received: April 4, 2013
Last updated: April 12, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)